J. B. Chemicals & Pharmaceuticals Limited (BOM: 506943)
India
· Delayed Price · Currency is INR | Market Cap | 297.13B |
| Revenue (ttm) | 35.92B |
| Net Income (ttm) | 5.87B |
| Shares Out | 155.29M |
| EPS (ttm) | 36.94 |
| PE Ratio | 51.80 |
| Forward PE | 39.30 |
| Dividend | 13.50 (0.70%) |
| Ex-Dividend Date | Aug 14, 2024 |
| Volume | 99 |
| Open | 1,915.65 |
| Previous Close | 1,935.15 |
| Day's Range | 1,910.00 - 1,978.00 |
| 52-Week Range | 1,246.05 - 2,029.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 8, 2024 |
About J. B. Chemicals & Pharmaceuticals
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-cen... [Read more]
Financial Performance
In 2023, J. B. Chemicals & Pharmaceuticals's revenue was 34.84 billion, an increase of 10.63% compared to the previous year's 31.49 billion. Earnings were 5.53 billion, an increase of 34.84%.
Financial StatementsNews
Torrent Is Said to Seek Raising $3 Billion for KKR’s Stake in JB
Torrent Pharmaceuticals Ltd. is considering raising as much as $3 billion from global banks as the Indian drugmaker seeks to acquire a controlling stake in JB Chemicals & Pharmaceuticals Ltd., accordi...